Pharmaceuticals and biotech sectors EQUITY: JAPAN PHARMACEUTICALS Overseas companies' earnings releases through 31 July Apr–Jun results announcements by AbbVie, Biogen, Bristol Myers Squibb, Bio-Rad Laboratories, and Neurocrine Biosciences AbbVie: Skyrizi and other in-house products benefiting from switches from Humira AbbVie (pharmaceuticals): AbbVie held its Apr–Jun earnings call on 31 July local time. (1) Sales of Humira fell 58.1% y-y amid biosimilar competition, but this was offset by Skyrizi (IL-23 in ...